Email Alert | RSS

Chinese Journal of Antituberculosis ›› 2011, Vol. 33 ›› Issue (11): 734-738.

Previous Articles     Next Articles

Analysis on the influencing factors of the mortality of  Mycobacterium tuberculosis and human immunodeficiency virus co-infection patients during the anti-tuberculosis treatment period

ZHOU Lin, CHEN Lei, WANG Ni, LIU Er-yong, HE Jin-ge, LIU Fei-ying, WANG Qiao-zhi, XUE Xiao   

  1. National Center for Tuberculosis Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China
  • Received:2011-06-15 Online:2011-11-10 Published:2012-01-20
  • Contact: ZHOU Lin E-mail:zhoulin@chinatb.org

Abstract: Objective  To understand the influencing factors of the mortality of  Mycobacterium tuberculosis and human immunodeficiency virus (Mtb/HIV) co-infection patients during the anti-tuberculosis treatment period.  Methods  During 2007—2008, patients from 6 counties in Guangxi, Sichuan, Hunan three provinces (autonomous region) were analyzed. 330 patients were observed, 33 patients died during the anti-tuberculosis treatment period.SAS 9.2 software was used to do the analysis of the impact of patients’ weight, CD4+T lymphocyte level, antiretroviral therapy period, HIV infection route, HIV infection years, tuberculosis type, OIs on the mortality during the antituberculosis period. There is a significant statistical difference when  P  value is below 0.05.   Results  The mortality of Mtb/HIV co-infection patients during anti-tuberculosis treatment period was 10.0%(33/330).Analysis on the influencing factors shows that: The logistic regression model is used to analyze the impact of CD4+T lymphocyte level and antiretroviral therapy on the mortality. The CD4 level has no impact on patients’ mortality(Wald χ2=0.5774, P=0.4473).The mortality of patients who received antiretroviral therapy is 7.612 times higher than that of those who didn’t receive antiretroviral therapy. Statistical test shows P  value is below 0.001(Wald χ2=14.8539).Whether the patient receives antiretroviral therapy is a influencing factor of the mortality;As for the HIV infection route, the mortality of sexually transmitted group was(6.7%,14/210),drug users group was (16.1%,19/118),drug users group have a higher risk of death.Fisher’s exact test shows P value is below 0.05, There is a significant statistical difference; As for the tuberculosis type, the mortality of smear positive pulmonary tuberculosis group was(20.9%,18/86), smear negative pulmonary tuberculosis group was(8.0%,14/174), pulmonary tuberculosis group was(11.7%,27/230), pulmonary tuberculosis with extra-pulmonary tuberculosis group was(16.7%,5/30),extra-pulmonary tuberculosis group was(1.4%,1/70),smear positive pulmonary tuberculosis and pulmonary tuberculosis with extra-pulmonary tuberculosis has a higher risk of death, χ2 test shows P  value is below 0.05(χ2=17.8685, 7.9687), There is a significant statistical difference.  Conclusion  TB/HIV co-infection patients’ pathological degree, health status are the major influencing factors of mortality.

Key words: Tuberculosis/therapy, HIV infections, Cause of death